Since the first description of Parkinson's disease in 1877 there have been numerous attempts to clarify the relative contribution of hereditary and environmental factors in its aetiology, Epidemiological and case-control studies as well as the existence of families with monogenic Parkinson's disease point clearly to a genetic contribution. Insights into the genetic basis of Parkinson's disease will lead to a greater understanding of the condition at a molecular level which will in turn allow the development of new rational therapeutic option. Curr Opin Neurol 12:427-432. (C) 1999 Lippincott Williams & Wilkins.
机构:
Univ Ulsan, Coll Med, Asan Med Ctr, Parkinson Alzheimer Ctr,Dept Neurol, Seoul, South KoreaUniv Ulsan, Coll Med, Asan Med Ctr, Parkinson Alzheimer Ctr,Dept Neurol, Seoul, South Korea
Chung, Sun Ju
[J].
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION,
2011,
54
(01):
: 70
-
78